Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2003 May;46(5):683-8.
doi: 10.1007/s00125-003-1086-8. Epub 2003 May 9.

Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients

Affiliations
Comparative Study

Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients

R A Malik et al. Diabetologia. 2003 May.

Abstract

Aims/hypothesis: The accurate detection, characterization and quantification of human diabetic neuropathy are important to define at risk patients, anticipate deterioration, and assess new therapies. Corneal confocal microscopy is a reiterative, rapid, non-invasive in vivo clinical examination technique capable of imaging corneal nerve fibres. The aim of this study was to define the ability of this technique to quantify the extent of degeneration and regeneration of corneal nerve fibres in diabetic patients with increasing neuropathic severity.

Methods: We scanned the cornea and collected images of Bowman's layer (containing a rich nerve plexus) from 18 diabetic patients and 18 age-matched control subjects.

Results: Corneal nerve fibre density (F(3)=9.6, p<0.0001), length (F(3)=23.8, p<0.0001), and branch density (F(3)=13.9, p<0.0001) were reduced in diabetic patients compared with control subjects, with a tendency for greater reduction in these measures with increasing severity of neuropathy.

Conclusion/interpretation: Corneal confocal microscopy is a rapid, non-invasive in vivo clinical examination technique which accurately defines the extent of corneal nerve damage and repair and acts as a surrogate measure of somatic neuropathy in diabetic patients. It could represent an advance to define the severity of neuropathy and expedite assessment of therapeutic efficacy in clinical trials of human diabetic neuropathy.

PubMed Disclaimer

References

    1. J Refract Surg. 1999 Jan-Feb;15(1):38-45 - PubMed
    1. Acta Neuropathol. 2001 Apr;101(4):367-74 - PubMed
    1. Invest Ophthalmol Vis Sci. 1982 Nov;23(5):671-4 - PubMed
    1. Electromyogr Clin Neurophysiol. 1999 Jul-Aug;39(5):267-72 - PubMed
    1. Am J Ophthalmol. 1995 Mar;119(3):288-94 - PubMed

Publication types

Substances